Jefferies reiterates SFBC at buy

SFBC International Inc. was reiterated by Jefferies & Co., Inc. analyst David Windley at a buy with a $27 price target in response to a company conference call. Jefferies learned a few modest negatives but the call also provided assurances. Tighter controls and efficiency should benefit operations. Shares of the Miami drug development services company were up 31 cents, or 1.39%, at $22.59 on volume of 1,328,449 shares versus the three-month running average of 2,212,160 shares. (Nasdaq: SFCC)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.